- Home
- STTK vs USAU Comparison
STTK vs USAU Comparison
Compare STTK & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- USAU
- Stock Information
- Founded
- STTK 2016
- USAU N/A
- Country
- STTK United States
- USAU United States
- Employees
- STTK N/A
- USAU N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- USAU Precious Metals
- Sector
- STTK Health Care
- USAU Basic Materials
- Exchange
- STTK Nasdaq
- USAU Nasdaq
- Market Cap
- STTK 56.8M
- USAU 68.1M
- IPO Year
- STTK 2020
- USAU N/A
- Fundamental
- Price
- STTK $1.23
- USAU $8.51
- Analyst Decision
- STTK Hold
- USAU Strong Buy
- Analyst Count
- STTK 3
- USAU 2
- Target Price
- STTK $2.00
- USAU $11.50
- AVG Volume (30 Days)
- STTK 127.4K
- USAU 150.5K
- Earning Date
- STTK 02-27-2025
- USAU 03-17-2025
- Dividend Yield
- STTK N/A
- USAU N/A
- EPS Growth
- STTK N/A
- USAU N/A
- EPS
- STTK N/A
- USAU N/A
- Revenue
- STTK $6,435,000.00
- USAU N/A
- Revenue This Year
- STTK $313.04
- USAU N/A
- Revenue Next Year
- STTK N/A
- USAU N/A
- P/E Ratio
- STTK N/A
- USAU N/A
- Revenue Growth
- STTK 382.75
- USAU N/A
- 52 Week Low
- STTK $0.94
- USAU $3.20
- 52 Week High
- STTK $11.76
- USAU $8.62
- Technical
- Relative Strength Index (RSI)
- STTK 52.10
- USAU 64.64
- Support Level
- STTK $1.11
- USAU $7.06
- Resistance Level
- STTK $1.36
- USAU $8.04
- Average True Range (ATR)
- STTK 0.11
- USAU 0.40
- MACD
- STTK 0.01
- USAU 0.10
- Stochastic Oscillator
- STTK 56.67
- USAU 85.81
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.